US Patent Issued to JANSSEN BIOTECH, PROTAGONIST THERAPEUTICS on Nov. 25 for "Lipidated peptide inhibitors of interleukin-23 receptor" (American, Italian Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,617, issued on Nov. 25, was assigned to JANSSEN BIOTECH INC. (Horsham, Pa.) and PROTAGONIST THERAPEUTICS INC. (Newark, Calif.).

"Lipidated peptide inhibitors of interleukin-23 receptor" was invented by Santhosh Neelamkavil (Spring House, Pa.), Chengzao Sun (Spring House, Pa.), Sandeep Somani (Spring House, Pa.), Stephanie A. Barros (Spring House, Pa.), Danila Branca (Pomezia, Italy), Ashok Bhandari (Newark, Calif.), James Daniel (Newark, Calif.), Tran Trung Tran (Newark, Calif.) and Brian Frederick (Newark, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to novel lipidated peptide inhibitors of the interleukin-23 ...